State-of-the-art, fully equipped & operational R & D Center located in Thane with an examination room, documentation room, planning room, laboratory facilities, OPD and a waiting lounge.
Clinical Trials
Clinical Trial Phase 1
Phase 1 clinical trials evaluate the safety of a given medicine to an individual
Clinical Trial Phase 2
Phase 2 clinical trials evaluate the effectiveness of a new therapy/ protocol/ treatment
Clinical Trial Phase 3
Phase 3 After the multiple lines of treatments like chemotherapy, targeted therapy, immunotherapy, radiotherapy, surgery are opted and there are no other options left, that’s where SUNACT offers its services. SUNACT provides “beyond the standard of care treatment” with higher response rates and reduced side effects.
Clinical Trial Phase 4
Once the treatment is available and approved, the long-term effects of the therapy observed with different parameters
CUP (Compassionate Usage Program)
Selected targeted, novel medicines, and immunotherapy available on a complimentary basis to the selected patients based on the molecular findings, analysis, and inclusion criteria of the study.
Patients with life-threatening illnesses who have exhausted all other treatment, after weighing all the risks and benefits, can be eligible for phase 1 trials.
Beyond The Standard Of Care (SOC) & Newer Drugs
SUNACT is one of it’s kind unique center to initiate the studies for new drugs/ medicine when most of the standard-of-care options are utilized for cancer treatment. If the multiple lines of treatments, like chemotherapy, targeted therapy, immunotherapy, radiotherapy, surgery, or no other options left, SUNACT provides the beyond the standard of care medicines with higher response rate and reduced side effects